Literature DB >> 23054192

Development and characterization of Xl1, a Xenopus laevis chondrocyte-like cell culture.

Natércia Conceição1, Michael Viegas, João Fidalgo, M Leonor Cancela.   

Abstract

We describe the development and characterization of a new cell line, designated Xl1, derived from vertebra and long bones of Xenopus laevis. These cells can mineralize their extracellular matrix upon addition of an inorganic phosphate donor and vitamin C, as characterized by von Kossa staining. In addition they express genes such as matrix gla protein (mgp), alkaline phosphatase, type II collagen, and retinoic acid receptors, representing a valuable tool to analyze expression and regulation of Xenopus cartilage-associated genes. Continuous treatment with retinoic acid (RA) inhibited mineralization, alkaline phosphatase expression and its activity, suggesting that RA is a potential negative regulator of Xl1 cell differentiation. These cells are receptive to efficient transfer of DNA using conventional methods including calcium phosphate, liposome-mediated transfer or electroporation and were found to express basal levels of mgp at least 50-fold higher than the routinely used Xenopus A6 cell line, as seen by transcription assays with the distal X. laevis mgp promoter. Being the first amphibian cell line derived from bone tissue, the Xl1 culture provides an excellent in vitro tool for functional promoter studies, being suitable, among other uses, for identifying promoter elements mediating cartilage-expressed genes as shown here for mgp.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23054192     DOI: 10.1007/s11010-012-1473-x

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  56 in total

1.  Inorganic phosphate added exogenously or released from beta-glycerophosphate initiates mineralization of osteoid nodules in vitro.

Authors:  C G Bellows; J N Heersche; J E Aubin
Journal:  Bone Miner       Date:  1992-04

2.  Pro-inflammatory cytokine tumor necrosis factor-alpha induces bone morphogenetic protein-2 in chondrocytes via mRNA stabilization and transcriptional up-regulation.

Authors:  Naoshi Fukui; Yasuko Ikeda; Toshiyuki Ohnuki; Atsuhiko Hikita; Sakae Tanaka; Shoji Yamane; Ryuji Suzuki; Linda J Sandell; Takahiro Ochi
Journal:  J Biol Chem       Date:  2006-07-11       Impact factor: 5.157

Review 3.  Structure and function of cartilage collagens.

Authors:  P Bruckner; M van der Rest
Journal:  Microsc Res Tech       Date:  1994-08-01       Impact factor: 2.769

4.  In situ measurement of collagen synthesis by human bone cells with a sirius red-based colorimetric microassay: effects of transforming growth factor beta2 and ascorbic acid 2-phosphate.

Authors:  H Tullberg-Reinert; G Jundt
Journal:  Histochem Cell Biol       Date:  1999-10       Impact factor: 4.304

5.  Effects of retinoic acid on the differentiation of chondrogenic progenitor cells, ATDC5.

Authors:  Akiko Kirimoto; Yuzo Takagi; Keiichi Ohya; Hitoyata Shimokawa
Journal:  J Med Dent Sci       Date:  2005-09

6.  Cell stage-dependent effects of ascorbic acid on cultured porcine bone cells.

Authors:  I Denis; A Pointillart; M Lieberherr
Journal:  Bone Miner       Date:  1994-05

7.  Retinoic acid receptor gamma-induced misregulation of chondrogenesis in the murine limb bud in vitro.

Authors:  Eugene Galdones; Barbara F Hales
Journal:  Toxicol Sci       Date:  2008-08-14       Impact factor: 4.849

8.  Sox9 is required for cartilage formation.

Authors:  W Bi; J M Deng; Z Zhang; R R Behringer; B de Crombrugghe
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

9.  Runx2 expression and action in chondrocytes are regulated by retinoid signaling and parathyroid hormone-related peptide (PTHrP).

Authors:  M Iwamoto; J Kitagaki; Y Tamamura; C Gentili; E Koyama; H Enomoto; T Komori; M Pacifici; M Enomoto-Iwamoto
Journal:  Osteoarthritis Cartilage       Date:  2003-01       Impact factor: 6.576

10.  A mesoderm-inducing factor is produced by Xenopus cell line.

Authors:  J C Smith
Journal:  Development       Date:  1987-01       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.